the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08. Quorum Information Technologies Inc has listed on the Toronto Venture Exchange (TSX-V) ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Major indexes were slightly lower Thursday morning after a couple of lackluster days for the U.S. stock market that followed ...
All three major indexes were muted in morning trading. In recent trading: The Dow industrials, S&P 500 and Nasdaq Composite wavered, switching from modest gains to small losses. Treasury yields ...
The pullback in U.S. stocks was advancing in Thursday afternoon trade, with the Dow and S&P 500 touching new session lows. The Dow Jones Industrial Average was down about 123 points, or 0.3%, near 43, ...
Investors will listen out for any comments about pricing pressures and the economy. In recent trading: The Dow industrials, S&P 500 and Nasdaq Composite edged down. Treasury yields slipped, after the ...
U.S. stocks ended lower on Thursday, putting a little more daylight between them and record territory claimed earlier in the week. Investors have been focused on what Donald Trump's second ...
Comments from Jerome Powell could set the tone for rate cuts as the market assesses the impact of a Republican sweep in D.C.
Secondly, it was a profit taking session on Wall Street with all the major indices recording losses overnight. Today, all ...
One of the challenges for investors trying to understand the implications of a Trump administration is that the goals seem to be contradictory: higher import tariffs and a lower dollar to help the ...
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Vanda Pharmaceuticals Inc. VNDA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year ...